Sabra Health Care REIT, Inc. (SBRA)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 90M 180M 270M Q3 '21: 128.6M Q4 '21: 135.7M Q1 '22: 163.1M Q2 '22: 156M Q3 '22: 140.8M Q4 '22: 165M Q1 '23: 161.3M Q2 '23: 161.2M Q3 '23: 161.6M Q4 '23: 163.4M Q1 '24: 166.7M Q2 '24: 176.1M Q3 '24: 178M Q4 '24: 182.3M Q1 '25: 183.5M Q2 '25: 189.2M Q3 '25: 190M Q4 '25: 211.9M Q1 '26: 221.8M Q2 '26: 235.9M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Gross Profit Quarterly

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Income Quarterly

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Net Income Quarterly

-90M -60M -30M 0 30M 60M 90M Q3 '21: 10.2M Q4 '21: -24.4M Q1 '22: 40.6M Q2 '22: 16.8M Q3 '22: -50.1M Q4 '22: -84.9M Q1 '23: -9.5M Q2 '23: 21.2M Q3 '23: -15.1M Q4 '23: 17.2M Q1 '24: 26.3M Q2 '24: 24M Q3 '24: 29.8M Q4 '24: 46.7M Q1 '25: 40.3M Q2 '25: 65.5M Q3 '25: 22.5M Q4 '25: 27.2M Q1 '26: 40.9M Q2 '26: -25.2M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Cost of Revenue Quarterly

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Cash Flow Quarterly

0 40M 80M 120M Q3 '21: 106.2M Q4 '21: 97.9M Q1 '22: 63.1M Q2 '22: 76.6M Q3 '22: 108.5M Q4 '22: 67.6M Q1 '23: 68.3M Q2 '23: 70.3M Q3 '23: 83.2M Q4 '23: 78.7M Q1 '24: 52.8M Q2 '24: 80.1M Q3 '24: 97.7M Q4 '24: 80M Q1 '25: 80.3M Q2 '25: 81M Q3 '25: 100M Q4 '25: 87.4M Q1 '26: 98.4M Q2 '26: 85.8M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Free Cash Flow Quarterly

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Shares Outstanding Quarterly

0 90M 180M 270M Q1 '20: 206M Q2 '20: 206.2M Q3 '20: 206.7M Q1 '21: 212.6M Q2 '21: 216.3M Q3 '21: 222.1M Q1 '22: 231.6M Q2 '22: 231.7M Q3 '22: 231M Q1 '23: 231.2M Q2 '23: 232.2M Q3 '23: 231.2M Q1 '24: 233.4M Q2 '24: 233.8M Q3 '24: 237M Q1 '25: 240.3M Q2 '25: 240.9M Q3 '25: 243.6M Q1 '26: 256M Q2 '26: 252.3M Q2 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-0.60 -0.30 0.00 0.30 0.60 0.90 Q3 '21: -0.22 Q4 '21: -0.51 Q1 '22: -0.49 Q2 '22: 0.19 Q3 '22: -0.08 Q4 '22: -0.34 Q1 '23: -0.56 Q2 '23: -0.54 Q3 '23: -0.39 Q4 '23: 0.05 Q1 '24: 0.20 Q2 '24: 0.21 Q3 '24: 0.41 Q4 '24: 0.54 Q1 '25: 0.60 Q2 '25: 0.77 Q3 '25: 0.73 Q4 '25: 0.64 Q1 '26: 0.63 Q2 '26: 0.26 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.